Company profile: Manhattan Scientifics
1.1 - Company Overview
Company description
- Provider of nanomedicine technology transfer and commercialization, including nanostructured metals that enhance strength and biocompatibility for medical devices; Magnetic Relaxometry cancer detection using superparamagnetic nanoparticles and sensitive magnetic detectors to identify and locate early-stage cancers; and MicroFuel Cell technology for 'always on' portable power in small electronics.
Products and services
- Magnetic Relaxometry (MRX) Cancer Detection: A nanoparticle-based system using superparamagnetic nanoparticles and sensitive magnetic detectors to identify and locate early-stage cancers with high specificity
- Nanostructured Metals: A nanostructuring method that increases metal strength and biocompatibility for medical devices, enabling stronger, more biocompatible medical components
- MicroFuel Cell Technology: An always-on power system for small electronics, producing continuous energy to keep devices operating persistently
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Manhattan Scientifics
Nanoconduction
HQ: United States
Website
- Description: Provider of carbon nanotube-based thermal management solutions for the microprocessor industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoconduction company profile →
Molecular Imprints
HQ: United States
Website
- Description: Provider of nanopatterning systems and solutions for the hard disk drive and semiconductor sectors, with over 100 issued patents covering imprint tools, materials and masks/templates, process technology and imprint-specific device designs; founded in 2001 in Austin, Texas as a University of Texas spin-out.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Imprints company profile →
N4 Pharma
HQ: United Kingdom
Website
- Description: Provider of drug reformulation solutions, developing and out-licensing new versions of existing and novel high-value drugs for unmet needs. Advances products to clinical proof of concept then partners for regulatory. Offerings include Nuvec, a silica nanoparticle system to protect and deliver siRNA, RNA, and DNA; LipTide, a lipid and peptide-based platform that mimics a natural virus for targeted RNA delivery; and ECP105, an siRNA therapy for post-surgical glaucoma by silencing MRTF-B.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full N4 Pharma company profile →
NX Filtration
HQ: The Netherlands
Website
- Description: Provider of water filtration membranes and tools, including direct nanofiltration for single-step removal of color, micropollutants and other contaminants; ultrafiltration to remove suspended solids, bacteria and viruses; microfiltration for larger particles used in beer and industrial processes; hollow fiber nanofiltration for low-fouling removal of organics and salinity; plus an online projection tool for dNF system design.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NX Filtration company profile →
Kontem
HQ: Germany
Website
- Description: Provider of phase contrast systems for transmission electron microscopes that significantly improve image quality, especially for biological applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kontem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Manhattan Scientifics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Manhattan Scientifics
2.2 - Growth funds investing in similar companies to Manhattan Scientifics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Manhattan Scientifics
4.2 - Public trading comparable groups for Manhattan Scientifics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →